Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add filters








Year range
1.
Indian J Med Ethics ; 2004 Oct-Dec; 1(4): 121
Article in English | IMSEAR | ID: sea-53390
2.
Indian J Exp Biol ; 1993 Apr; 31(4): 360-4
Article in English | IMSEAR | ID: sea-58127

ABSTRACT

IDPH-791, when injected (ip) to mice potentiated the pentobarbitone sleeping time in a dose dependent manner. Involvement of neurotransmitters and receptors in this effect was studied using various receptor blockers, enzyme inhibitors, agonist and an amine depletor. Pretreatment with high dose of yohimbine (0.5 mg/kg), haloperidol, cyproheptadine, atropine and a combination of atropine and yohimbine significantly reversed the activity. Physostigmine, diethyldithiocarbamate and high dose of apomorphine (2.5 mg/kg) potentiated the subminimal effect of IDPH-791, whereas low dose of apomorphine (0.1 mg/kg) failed to potentiate. However, reserpine significantly reversed this response. Prazosin, phenoxybenzamine, low dose of yohimbine (0.25 mg/kg), propranolol, methysergide, mepyramine and cimetidine did not produce any change, thus ruling out the involvement of adrenergic, serotonergic and histaminergic systems. There seems to be simultaneous involvement of muscarinic receptors and postsynaptic dopamine (D2) receptors in IDPH-791 induced potentiation of pentobarbitone hypnosis.


Subject(s)
Animals , Cholinesterase Inhibitors/pharmacology , Dose-Response Relationship, Drug , Male , Mice , Muscle Relaxants, Central/pharmacology , Pentobarbital , Receptors, Neurotransmitter/antagonists & inhibitors , Reserpine/pharmacology , Sleep/drug effects , Thiazines/pharmacology , Triazoles/pharmacology
5.
Indian J Physiol Pharmacol ; 1987 Jan-Mar; 31(1): 25-9
Article in English | IMSEAR | ID: sea-108497

ABSTRACT

'Arogyavardhini'-an indigenous formulation was evaluated for its hepatoprotective activity in rats, using two models of carbon tetrachloride (CCl4) hepatic damage, one simulating vital hepatitis and the other simulating fatty change. The protective effect was assessed from serum aspartate transaminase (AST) and alkaline phosphatase levels and from histopathological changes in liver. The results revealed that 'Arogyavardhini' (5 mg/100g, PO daily) was effective in minimizing the changes in serum levels of AST and alkaline phosphatase induced by CCI. The protective effect was also evident on histopathological examination.


Subject(s)
Alkaline Phosphatase/blood , Animals , Aspartate Aminotransferases/blood , Carbon Tetrachloride Poisoning/prevention & control , Drug Combinations/pharmacology , Fatty Liver/prevention & control , Hepatitis, Viral, Animal/prevention & control , Liver/drug effects , Male , Medicine, Ayurvedic , Metals/pharmacology , Plant Extracts/pharmacology , Rats
7.
Indian J Physiol Pharmacol ; 1963 Jul; 7(): 153-7
Article in English | IMSEAR | ID: sea-107651
9.
J Indian Med Assoc ; 1963 Jan; 40(): 11-2
Article in English | IMSEAR | ID: sea-101535
10.
J Indian Med Assoc ; 1963 Jan; 40(): 11-2
Article in English | IMSEAR | ID: sea-96876
15.
Indian J Physiol Pharmacol ; 1960 Jan; 4(): 1-16
Article in English | IMSEAR | ID: sea-108940
SELECTION OF CITATIONS
SEARCH DETAIL